We are live on ! Find out more
HAE icon

Haemonetics
HAE

170 hedge funds and large institutions have $1.86B invested in Haemonetics in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 55 increasing their positions, 75 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less capital invested

Capital invested by funds: $1.95B → $1.86B (-$86.6M)

3% less funds holding

Funds holding: 175 → 170 (-5)

3.54% less ownership

Funds ownership: 107.15% → 103.61% (-3.5%)

16% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 19

27% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 75

Holders
170
Holders Change
-5
Holders Change %
-2.86%
% of All Funds
4.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
55
Reduced
75
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$35.6M
2
VNIM
Vaughan Nelson Investment Management
Texas
+$8.49M
3
BCIM
Black Creek Investment Management
Ontario, Canada
+$7.19M
4
UBS AM
UBS AM
Illinois
+$6.81M
5
PTC
Petrus Trust Company
Texas
+$5.02M

Top Sellers

1
CCM
Camber Capital Management
Massachusetts
-$35.3M
2
Nordea Investment Management
Nordea Investment Management
Sweden
-$15.1M
3
Neuberger Berman Group
Neuberger Berman Group
New York
-$13.1M
4
PIM
Perkins Investment Management
Illinois
-$10.4M
5
Norges Bank
Norges Bank
Norway
-$9.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
151
Bank of Montreal
Ontario, Canada
$61K -$13.2K -369 -17%
GGPS
152
Gary Goldberg Planning Services
New York
$60K -$3.39K -95 -5%
SO
153
STRS Ohio
Ohio
$52K +$39.3K +1,100 +275%
PNC Financial Services Group
154
PNC Financial Services Group
Pennsylvania
$41K – – –
Envestnet Asset Management
155
Envestnet Asset Management
Illinois
$21K +$2.25K +63 +12%
LTFS
156
Ladenburg Thalmann Financial Services
Florida
$21K +$3.85K +108 +21%
MA
157
MUFG Americas
New York
$19K – – –
FHA
158
First Horizon Advisors
Tennessee
$17K +$8.67K +243 +94%
Federated Hermes
159
Federated Hermes
Pennsylvania
$6K -$56.1K -1,572 -89%
IPC
160
Independent Portfolio Consultants
Florida
$6K +$6.07K +170 New
GAM
161
Gemmer Asset Management
California
$4K – – –
WA
162
Waverly Advisors
Alabama
$4K – – –
WT
163
Whittier Trust
California
$4K – – –
Fifth Third Bancorp
164
Fifth Third Bancorp
Ohio
$3K -$7.64K -214 -69%
GT
165
Glenmede Trust
Pennsylvania
$3K -$5.35K -150 -60%
WA
166
WFG Advisors
Texas
$2K +$1.43K +40 +222%
Creative Planning
167
Creative Planning
Kansas
$2K +$1.61K +45 New
CGT
168
Capital Guardian Trust
California
$2K +$1.96K +55 New
Manulife (Manufacturers Life Insurance)
169
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.18K +$39.3K +1,102 +3%
Northwestern Mutual Wealth Management
170
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
CCM
171
Camber Capital Management
Massachusetts
– -$35.3M -1,000,000 Closed
Nordea Investment Management
172
Nordea Investment Management
Sweden
– -$15.1M -427,946 Closed
Two Sigma Advisers
173
Two Sigma Advisers
New York
– -$4.38M -124,005 Closed
TC
174
TFS Capital
Pennsylvania
– -$3.21M -90,988 Closed
WI
175
WHV Investments
California
– -$1.87M -53,000 Closed
4 5 6
7
8

HAE Hedge Fund Activity: Q3 2014 in Review

170 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q3 2014, worth a combined $1.86B — down 4.5% from $1.95B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of HAE and 16 opened new positions — a net loss of 3 holders — while 75 trimmed existing stakes and 55 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $35.6M. The largest seller was Camber Capital Management, exiting entirely with an estimated $35.3M sold.

  • 170 institutional investors held Haemonetics (HAE) as of Q3 2014, down from 175 in Q2 2014.
  • Funds reported $1.86B of Haemonetics stock for Q3 2014, down 4.5% quarter-over-quarter.
  • 16 funds opened new Haemonetics positions in Q3 2014 and 19 closed out, a net change of -3 holders.
  • The largest Haemonetics buyer in Q3 2014 was T. Rowe Price Associates, an estimated $35.6M added.
  • The largest Haemonetics seller in Q3 2014 was Camber Capital Management, an estimated $35.3M sold.

Based on aggregated 13F filings for Q3 2014.